Sarilumab
Drug timelines are a Plus or Pro feature.
30 regulatory and trial events tracked for Sarilumab, covering 2014-01-28 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer. [Phase 1]